| Literature DB >> 23683345 |
Maya Gobin1, Neville Verlander, Carla Maurici, Angie Bone, Anthony Nardone.
Abstract
BACKGROUND: A national multimedia campaign was launched in January 2010, to increase the proportion of young people tested for chlamydia. This study aimed to evaluate the impact of the campaign on the coverage and positivity within the National Chlamydia Screening Programme (NSCP) in England.Entities:
Mesh:
Year: 2013 PMID: 23683345 PMCID: PMC3671151 DOI: 10.1186/1471-2458-13-484
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Figure 1Flowchart of records included in the final coverage and positivity analysis.
Figure 2Number of Chlamydia tests and proportion positive from 1st April 2008 to 30th June 2010.
Demographic characteristics of individuals included in each phase for the coverage analyses
| 1025863 | 327675 | 201601 | ||
| (100) | (100) | (100) | ||
| 313692 | 128818 | 70278 | ||
| (30.58) | (39.31) | (34.86) | ||
| | 712171 | 198857 | 131323 | |
| (69.42) | (60.69) | (65.14) | ||
| 573332 | 185464 | 110161 | ||
| (55.89) | (56.60) | (54.64) | ||
| | 452531 | 142211 | 91440 | |
| (44.11) | (43.40) | (45.36) | ||
| 298433 | 93523 | 62265 | ||
| (29.09) | (28.54) | (30.89) | ||
| | 236452 | 76224 | 46812 | |
| (23.05) | (23.26) | (23.22) | ||
| | 186571 | 61181 | 36530 | |
| (18.19) | (18.67) | (18.12) | ||
| | 161345 | 51181 | 30145 | |
| (15.73) | (15.62) | (14.95) | ||
| | 143062 | 45566 | 25849 | |
| (13.95) | (13.91) | (12.82) | ||
| 876975 | 283011 | 172849 | ||
| (85.49) | (86.37) | (85.74) | ||
| | 63885 | 16247 | 11519 | |
| (6.23) | (4.96) | (5.71) | ||
| | 36938 | 14453 | 8522 | |
| (3.60) | (4.41) | (4.23) | ||
| | 48065 | 13964 | 8711 | |
| (4.69) | (4.26) | (4.32) | ||
*614,772 (28%) Observations excluded because of missing/unknown sex, deprivation, age and ethnicity.
Relative change in testing during and after the campaign and by socio-demographic characteristics
| Crude RR | | Pre | 1 | | <0.001~ |
| | During | 2.23 | (2.22 to 2.41) | | |
| | Post | 1.38 | (1.37 to 1.38) | | |
| Adjusted RRx | | Pre | 1 | | 0.50~ |
| | During | 0.91 | (0.72 to 1.14) | | |
| | Post | 0.88 | (0.69 to 1.11) | | |
| Pre | 1 | | <0.001~ | ||
| | During | 1.10 | (1.02 to 1.19) | | |
| | Post | 0.91 | (0.84 to 0.99) | | |
| Pre | 1 | | | ||
| | During | 0.71 | (0.66 to 0.77) | | |
| | Post | 0.72 | (0.66 to 0.79) | | |
| | 1 | | <0.001* | ||
| | | 0.67 | (0.65 to 0.69) | | |
| | 1 | | <0.001* | ||
| | 0.59 | (0.57 to 0.62) | | ||
| | 0.38 | (0.36 to 0.39) | | ||
| | 0.27 | (0.26 to 0.28) | | ||
| | 0.23 | (0.22 to 0.24) | | ||
| Pre | 1 | | <0.001~ | ||
| | During | 0.91 | (0.83 to 1.00) | | |
| | Post | 0.79 | (0.72 to 0.88) | | |
| Pre | 1 | | | ||
| | During | 0.78 | (0.71 to 0.86) | | |
| | Post | 0.74 | (0.67 to 0.82) | | |
| Pre | 1 | | | ||
| | During | 1.12 | (1.01 to 1.24) | | |
| | Post | 0.98 | (0.88 to 1.09) | | |
| Pre | 1 | | | ||
| | During | 0.81 | (0.74 to 0.90) | | |
| Post | 0.75 | (0.67 to 0.83) | |||
Legend: RR, Risk ratio; CI, Confidence interval x adjusted for cyclical and secular trends, *Wald test for socio-demographic variable, ~ likelihood ratio test for interaction in stage III, phase in stages I and II.
Demographic characteristics of individuals included in each phase for the positivity analyses
| 1417873 | 468009 | 284029 | ||
| (6.65) | (4.72) | (5.22) | ||
| 458812 | 193775 | 104740 | ||
| (5.60) | (3.68) | (4.32) | ||
| | 954824 | 272873 | 178396 | |
| (7.16) | (5.47) | (5.75) | ||
| | 4237 | 1361 | 893 | |
| (6.09) | (4.63) | (3.70) | ||
| 808334 | 272737 | 158652 | ||
| (6.56) | (4.43) | (5.00) | ||
| | 609539 | 195272 | 125377 | |
| (6.78) | (5.14) | (5.49) | ||
| 403063 | 129909 | 87207 | ||
| (7.89) | (5.59) | (5.90) | ||
| | 325252 | 108604 | 64290 | |
| (6.82) | (4.82) | (5.36) | ||
| | 253380 | 87668 | 50397 | |
| (6.09) | (4.42) | (4.92) | ||
| | 212359 | 71750 | 41427 | |
| (5.85) | (4.21) | (4.94) | ||
| | 186474 | 63326 | 36255 | |
| (5.16) | (3.79) | (4.20) | ||
| | 37345 | 6752 | 4453 | |
| (7.56) | (4.80) | (4.11) | ||
| 905090 | 287450 | 175135 | ||
| (6.94) | (5.06) | (5.58) | ||
| | 66128 | 16785 | 12042 | |
| (8.25) | (6.61) | (7.51) | ||
| | 37882 | 14763 | 8778 | |
| (2.28) | (1.66) | (1.88) | ||
| | 49532 | 14260 | 8934 | |
| (7.64) | (6.00) | (6.63) | ||
| | 359241 | 134751 | 79140 | |
| (5.95) | (3.98) | (4.29) | ||
| 552570 | 152441 | 93649 | ||
| (8.81) | (6.87) | (7.16) | ||
| | 330365 | 89744 | 50719 | |
| (4.66) | (3.28) | (4.00) | ||
| | 534938 | 225824 | 139661 | |
| (5.65) | (3.85) | (4.36) | ||
Relative change in positivity of Chlamydia testing during and after the campaign and by socio-demographic characteristics
| | Pre | 1 | | <0.001 | |
| During | 0.70 | (0.67 to 0.71) | | ||
| Post | 0.77 | (0.76 to 0.79) | | ||
| | Pre | 1 | | <0.001 | |
| | During | 1.18 | (1.13 to 1.23) | | |
| | Post | 1.40 | (1.30 to 1.51) | | |
| Pre | 1 | | <0.001 | ||
| | During | 1.04 | (0.99 to 1.10) | | |
| | Post | 1.30 | (1.20 to 1.41) | | |
| Pre | 1 | | | ||
| | During | 1.19 | (1.14 to 1.25) | | |
| | Post | 1.35 | (1.25 to 1.46) | | |
| Pre | 1 | | | ||
| | During | 1.26 | (0.88 to 1.81) | | |
| | Post | 0.85 | (0.50 to 1.43) | | |
| Pre | 1 | | <0.001 | ||
| | During | 1.10 | (1.05 to 1.15) | | |
| | Post | 1.31 | (1.21 to 1.42) | | |
| Pre | 1 | | | ||
| | During | 1.20 | (1.15 to 1.26) | | |
| | Post | 1.37 | (1.27 to 1.48) | | |
| Pre | 1 | | 0.005 | ||
| | During | 1.13 | (1.08 to 1.19) | | |
| | Post | 1.30 | (1.20 to 1.41) | | |
| Pre | 1 | | | ||
| | During | 1.13 | (1.07 to 1.19) | | |
| | Post | 1.34 | (1.24 to 1.46) | | |
| Pre | 1 | | | ||
| | During | 1.16 | (1.10 to 1.22) | | |
| | Post | 1.36 | (1.25 to 1.48) | | |
| Pre | 1 | | | ||
| | During | 1.16 | (1.09 to 1.23) | | |
| | Post | 1.44 | (1.32 to 1.57) | | |
| Pre | 1 | | | ||
| | During | 1.17 | (1.10 to 1.25) | | |
| | Post | 1.36 | (1.24 to 1.49) | | |
| Pre | 1 | | | ||
| | During | 1.06 | (0.93 to 1.20) | | |
| | Post | 0.98 | (0.81 to 1.17) | | |
| Pre | 1 | | <0.001 | ||
| | During | 1.15 | (1.10 to 1.20) | | |
| | Post | 1.35 | (1.25 to 1.46) | | |
| Pre | 1 | | | ||
| | During | 1.25 | (1.15 to 1.35) | | |
| | Post | 1.57 | (1.41 to 1.75) | | |
| Pre | 1 | | | ||
| | During | 1.25 | (1.05 to 1.49) | | |
| | Post | 1.40 | (1.13 to 1.74) | | |
| Pre | 1 | | | ||
| | During | 1.25 | (1.14 to 1.37) | | |
| | Post | 1.46 | (1.29 to 1.65) | | |
| Pre | 1 | | | ||
| | During | 1.08 | (1.03 to 1.14) | | |
| | Post | 1.23 | (1.13 to 1.33) | | |
| Pre | 1 | | <0.001 | ||
| | During | 1.21 | (1.16 to 1.27) | | |
| | Post | 1.36 | (1.25 to 1.46) | | |
| Pre | 1 | | | ||
| | During | 1.10 | (1.04 to 1.17) | | |
| | Post | 1.42 | (1.30 to 1.55) | | |
| Pre | 1 | | | ||
| | During | 1.08 | (1.03 to 1.13) | | |
| Post | 1.28 | (1.18 to 1.39) | |||
Legend OR, Odds ratio; CI, Confidence interval x adjusted for cyclical and secular trends *likelihood ratio test for interaction in stage III, phase in stages I and II.